EASD 2025
15 - 19 September 2025
The evolving role of GLP-1RAs for holistic cardiovascular, kidney, liver and metabolic care
Meeting description
04:10
Wednesday, 17 September 2025
17:45 - 17:50
(CEST)
Welcome and introduction
Steven E. Kahn
17:50 - 18:05
(CEST)
Stepping up holistic care: incretin-based and novel combination therapies in obesity
John Wilding
18:05 - 18:20
(CEST)
Taking the next step: the role of GLP-1RAs in the CKD and T2D nexus
Paola Fioretto
18:20 - 18:35
(CEST)
Integrating MASH in the CKM syndrome: the potential role of GLP-1RAs for the missing link
Eric Lawitz
18:35 - 18:50
(CEST)
At the end of the road: managing subclinical and clinical CVD with incretin-based and novel combination therapies
Subodh Verma
18:50 - 18:55
(CEST)
Looking into the future: advancing CKM management strategies
Steven E. Kahn
18:55 - 19:15
(CEST)
Q&A
Steven E. Kahn, John Wilding, Paola Fioretto, Eric Lawitz, Subodh Verma
Keywords